NO991175L - Anvendelse av proteiner som midler mot autoimmune sykdommer - Google Patents

Anvendelse av proteiner som midler mot autoimmune sykdommer

Info

Publication number
NO991175L
NO991175L NO991175A NO991175A NO991175L NO 991175 L NO991175 L NO 991175L NO 991175 A NO991175 A NO 991175A NO 991175 A NO991175 A NO 991175A NO 991175 L NO991175 L NO 991175L
Authority
NO
Norway
Prior art keywords
proteins
agents
autoimmune diseases
autoimmune
diseases
Prior art date
Application number
NO991175A
Other languages
English (en)
Other versions
NO991175D0 (no
Inventor
Alberto E Panerai
Alberto Bartorelli
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI961921 external-priority patent/IT1284555B1/it
Priority claimed from ITMI961922 external-priority patent/IT1284556B1/it
Priority claimed from ITMI961919 external-priority patent/IT1284553B1/it
Priority claimed from ITMI961920 external-priority patent/IT1284554B1/it
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of NO991175L publication Critical patent/NO991175L/no
Publication of NO991175D0 publication Critical patent/NO991175D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/846—Liver

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO991175A 1996-09-18 1999-03-10 Anvendelse av proteiner som midler mot autoimmune sykdommer NO991175D0 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITMI961921 IT1284555B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antidiabetici
ITMI961922 IT1284556B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti contro la sclerosi multipla
ITMI961919 IT1284553B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antiartritici
ITMI961920 IT1284554B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antiaterosclerotici
PCT/EP1997/005079 WO1998011909A1 (en) 1996-09-18 1997-09-17 Use of proteins as agents against autoimmune diseases

Publications (2)

Publication Number Publication Date
NO991175L true NO991175L (no) 1999-03-10
NO991175D0 NO991175D0 (no) 1999-03-10

Family

ID=27453037

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991175A NO991175D0 (no) 1996-09-18 1999-03-10 Anvendelse av proteiner som midler mot autoimmune sykdommer

Country Status (22)

Country Link
US (2) US6468536B1 (no)
EP (1) EP0928197B1 (no)
JP (1) JP2001501925A (no)
KR (1) KR20000036207A (no)
CN (1) CN1151838C (no)
AR (1) AR009952A1 (no)
AT (1) ATE233569T1 (no)
AU (1) AU723669B2 (no)
BR (1) BR9711499A (no)
CA (1) CA2266346A1 (no)
CZ (1) CZ293926B6 (no)
DE (1) DE69719525T2 (no)
DK (1) DK0928197T3 (no)
ES (1) ES2192669T3 (no)
IL (1) IL129024A0 (no)
NO (1) NO991175D0 (no)
NZ (1) NZ334714A (no)
PL (1) PL188746B1 (no)
PT (1) PT928197E (no)
RU (1) RU2196606C2 (no)
TR (1) TR199900596T2 (no)
WO (1) WO1998011909A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112655B1 (en) 1997-02-27 2006-09-26 Japan Tobacco, Inc. JTT-1 protein and methods of inhibiting lymphocyte activation
JP3521382B2 (ja) 1997-02-27 2004-04-19 日本たばこ産業株式会社 細胞間接着及びシグナル伝達を媒介する細胞表面分子
IT1290828B1 (it) 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
JP4210454B2 (ja) 2001-03-27 2009-01-21 日本たばこ産業株式会社 炎症性腸疾患治療剤
JP3871503B2 (ja) 1999-08-30 2007-01-24 日本たばこ産業株式会社 免疫性疾患治療剤
JP3597140B2 (ja) 2000-05-18 2004-12-02 日本たばこ産業株式会社 副刺激伝達分子ａｉｌｉｍに対するヒトモノクローナル抗体及びその医薬用途
CA2411428A1 (en) * 2000-06-08 2001-12-13 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
JP4212278B2 (ja) 2001-03-01 2009-01-21 日本たばこ産業株式会社 移植片拒絶反応抑制剤
ITMI20010761A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 per il trattamento e la prevenzione dell'epatite cronica attiva
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
JP2007517808A (ja) * 2004-01-16 2007-07-05 キュビオ リミテッド Ｔｏｌｌ様受容体誘導性のサイトカインおよびケモカイン分泌のシャペロニン１０調節

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024247A (en) 1971-12-27 1977-05-17 Palolab Pharmaceuticals Corporation Composition and method of using a protein mixture derived from liver
IT1244879B (it) 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
FR2688227A1 (fr) 1992-03-04 1993-09-10 Inst Nat Sante Rech Med Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
IT1270618B (it) 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39

Also Published As

Publication number Publication date
PL188746B1 (pl) 2005-04-29
ES2192669T3 (es) 2003-10-16
ATE233569T1 (de) 2003-03-15
PT928197E (pt) 2003-06-30
CZ293926B6 (cs) 2004-08-18
AR009952A1 (es) 2000-05-17
CA2266346A1 (en) 1998-03-26
DE69719525D1 (de) 2003-04-10
KR20000036207A (ko) 2000-06-26
DE69719525T2 (de) 2003-10-02
NO991175D0 (no) 1999-03-10
TR199900596T2 (xx) 1999-06-21
BR9711499A (pt) 1999-08-24
WO1998011909A1 (en) 1998-03-26
DK0928197T3 (da) 2003-06-23
JP2001501925A (ja) 2001-02-13
EP0928197B1 (en) 2003-03-05
AU4774797A (en) 1998-04-14
CZ91599A3 (cs) 1999-08-11
EP0928197A1 (en) 1999-07-14
AU723669B2 (en) 2000-08-31
US6468536B1 (en) 2002-10-22
CN1230892A (zh) 1999-10-06
PL332282A1 (en) 1999-08-30
NZ334714A (en) 2000-08-25
CN1151838C (zh) 2004-06-02
IL129024A0 (en) 2000-02-17
US20030108558A1 (en) 2003-06-12
RU2196606C2 (ru) 2003-01-20

Similar Documents

Publication Publication Date Title
NO995134L (no) Forbedrede fremgangsmåter for fremstilling av aktivert protein C
NO992806D0 (no) Terapeutiske midler
NO995712D0 (no) Oftalmiske preparater
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
NO991175D0 (no) Anvendelse av proteiner som midler mot autoimmune sykdommer
ID21424A (id) Konfigurasi katup gabungan untuk unit siklus-uap
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
MA23794A1 (fr) Utilisation de phenylcyclohexylcarboxamides
NO985571D0 (no) Legemiddel for autoimmunsykdommer
EE200000055A (et) Protsess tsüklopropüülatsetüleeni valmistamiseks
NO980058D0 (no) Opthalmiske preparater
TR199701666A3 (tr) Sismanliga karsi proteinler
DE69733607D1 (de) Herstellung von cycloalkyldiarylphosphinen
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
DE69737529D1 (de) Herstellung von 1-butyl-4-piperidinylmethylamin
NO991174L (no) Anvendelse av proteiner som anti-retrovirale midler
ID22787A (id) Nitro-benzamida berguna sebagai zat anti - arritimia
FI954857L (fi) Olefiinien runkoisomerointi
DE69523817D1 (de) Desodorisierende Präparate
HUP9904268A3 (en) Use of proteins as agents against autoimmune diseases
SI0928197T1 (en) Use of proteins as agents against autoimmune diseases
KR960011685U (ko) 조명등 결합구조
ZA978363B (en) Use of proteins as agents against autoimmune diseases.
SE9703137D0 (sv) Novel treatment of autoimmune diseases
KR980001951U (ko) 승합 차량의 정차스위치

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application